Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

1.

Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia.

Awad G, Hassan M, Loebel A, Hsu J, Pikalov A, Rajagopalan K.

BMC Psychiatry. 2014 Feb 23;14:53. doi: 10.1186/1471-244X-14-53.

PMID:
24559217
[PubMed - in process]
Free PMC Article
2.

Reasons and clinical outcomes of antipsychotic treatment switch in outpatients with schizophrenia in real-life clinical settings: the ETOS observational study.

Roussidis A, Kalkavoura C, Dimelis D, Theodorou A, Ioannidou I, Mellos E, Mylonaki T, Spyropoulou A, Yfantis A.

Ann Gen Psychiatry. 2013 Dec 20;12(1):42. doi: 10.1186/1744-859X-12-42.

PMID:
24359635
[PubMed]
Free PMC Article
3.

Patients' and clinicians' attitude towards long-acting depot antipsychotics in subjects with a first episode of psychosis.

Kirschner M, Theodoridou A, Fusar-Poli P, Kaiser S, Jäger M.

Ther Adv Psychopharmacol. 2013 Apr;3(2):89-99. doi: 10.1177/2045125312464106.

PMID:
24167680
[PubMed]
Free PMC Article
4.

Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review.

Olivares JM, Sermon J, Hemels M, Schreiner A.

Ann Gen Psychiatry. 2013 Oct 23;12(1):32. doi: 10.1186/1744-859X-12-32.

PMID:
24148707
[PubMed]
Free PMC Article
5.

Antipsychotic adherence patterns and health care utilization and costs among patients discharged after a schizophrenia-related hospitalization.

Markowitz M, Karve S, Panish J, Candrilli SD, Alphs L.

BMC Psychiatry. 2013 Oct 5;13:246. doi: 10.1186/1471-244X-13-246.

PMID:
24094241
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US.

O'Day K, Rajagopalan K, Meyer K, Pikalov A, Loebel A.

Clinicoecon Outcomes Res. 2013 Sep 13;5:459-70. doi: 10.2147/CEOR.S47990. eCollection 2013.

PMID:
24049452
[PubMed]
Free PMC Article
7.

Predictors of psychiatric hospitalization during 6 months of maintenance treatment with olanzapine long-acting injection: post hoc analysis of a randomized, double-blind study.

Ascher-Svanum H, Novick D, Haro JM, Bertsch J, McDonnell D, Detke H.

BMC Psychiatry. 2013 Sep 16;13:224. doi: 10.1186/1471-244X-13-224.

PMID:
24041270
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The personal, societal, and economic burden of schizophrenia in the People's Republic of China: implications for antipsychotic therapy.

Montgomery W, Liu L, Stensland MD, Xue HB, Treuer T, Ascher-Svanum H.

Clinicoecon Outcomes Res. 2013 Aug 14;5:407-18. doi: 10.2147/CEOR.S44325. eCollection 2013.

PMID:
23983478
[PubMed]
Free PMC Article
9.

Expansion of guidance for the day 8 initiation dose of paliperidone palmitate to avoid a missed dose.

Samtani MN, Nuamah I, Gopal S, Remmerie B, Kern Sliwa J, Alphs L.

Neuropsychiatr Dis Treat. 2013;9:721-30. doi: 10.2147/NDT.S40836. Epub 2013 May 20.

PMID:
23723704
[PubMed]
Free PMC Article
10.

Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia.

Dilla T, Ciudad A, Alvarez M.

Patient Prefer Adherence. 2013 Apr 4;7:275-84. doi: 10.2147/PPA.S41609. Print 2013.

PMID:
23589681
[PubMed]
Free PMC Article
11.

Association between adherence to and persistence with atypical antipsychotics and psychiatric relapse among US Medicaid-enrolled patients with schizophrenia.

Panish J, Karve S, Candrilli SD, Dirani R.

J Pharm Health Serv Res. 2013 Mar;4(1):29-39. Epub 2013 Jan 7.

PMID:
23486693
[PubMed]
Free PMC Article
12.

Quality of life is predictive of relapse in schizophrenia.

Boyer L, Millier A, Perthame E, Aballea S, Auquier P, Toumi M.

BMC Psychiatry. 2013 Jan 9;13:15. doi: 10.1186/1471-244X-13-15.

PMID:
23302219
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Economic burden associated with extrapyramidal symptoms in a medicaid population with schizophrenia.

Abouzaid S, Tian H, Zhou H, Kahler KH, Harris M, Kim E.

Community Ment Health J. 2014 Jan;50(1):51-8. doi: 10.1007/s10597-012-9561-7. Epub 2012 Nov 16.

PMID:
23229052
[PubMed - in process]
Free PMC Article
14.

Long-term healthcare costs and functional outcomes associated with lack of remission in schizophrenia: a post-hoc analysis of a prospective observational study.

Haynes VS, Zhu B, Stauffer VL, Kinon BJ, Stensland MD, Xu L, Ascher-Svanum H.

BMC Psychiatry. 2012 Dec 5;12:222. doi: 10.1186/1471-244X-12-222.

PMID:
23216976
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Estimated economic benefits from low-frequency administration of atypical antipsychotics in treatment of schizophrenia: a decision model.

Furiak NM, Gahn JC, Klein RW, Camper SB, Summers KH.

Ann Gen Psychiatry. 2012 Nov 16;11(1):29. doi: 10.1186/1744-859X-11-29.

PMID:
23157721
[PubMed]
Free PMC Article
16.

Sulfotransferase 4A1 Haplotype 1 (SULT4A1-1) Is Associated With Decreased Hospitalization Events in Antipsychotic-Treated Patients With Schizophrenia.

Liu Q, Ramsey TL, Meltzer HY, Massey BW, Padmanabhan S, Brennan MD.

Prim Care Companion CNS Disord. 2012;14(3). pii: PCC.11m01293. doi: 10.4088/PCC.11m01293. Epub 2012 Jun 24.

PMID:
23106027
[PubMed]
Free PMC Article
17.

Treatment adherence with early prescription of long-acting injectable antipsychotics in recent-onset schizophrenia.

Viala A, Cornic F, Vacheron MN.

Schizophr Res Treatment. 2012;2012:368687. doi: 10.1155/2012/368687. Epub 2012 Apr 3.

PMID:
22966435
[PubMed]
Free PMC Article
18.

Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: a retrospective cohort study.

Berger A, Edelsberg J, Sanders KN, Alvir JM, Mychaskiw MA, Oster G.

BMC Psychiatry. 2012 Aug 2;12:99. doi: 10.1186/1471-244X-12-99.

PMID:
22856540
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

The costs of schizophrenia and predictors of hospitalisation from the statutory health insurance perspective.

Zeidler J, Slawik L, Fleischmann J, Greiner W.

Health Econ Rev. 2012 May 4;2(1):9. doi: 10.1186/2191-1991-2-9.

PMID:
22828440
[PubMed]
Free PMC Article
20.

A pilot study on community-based outpatient treatment for patients with chronic psychotic disorders in Somalia: Change in symptoms, functioning and co-morbid khat use.

Odenwald M, Lingenfelder B, Peschel W, Haibe FA, Warsame AM, Omer A, Stöckel J, Maedl A, Elbert T.

Int J Ment Health Syst. 2012 Jul 2;6(1):8. doi: 10.1186/1752-4458-6-8.

PMID:
22747911
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk